Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025)

Historic Short-term Investments for Sunshine Biopharma (SBFM) over the last 5 years, with Q1 2025 value amounting to $70457.0.

  • Sunshine Biopharma's Short-term Investments changed N/A to $70457.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $70457.0, marking a year-over-year change of. This contributed to the annual value of $7590.0 for FY2021, which is 0.0% changed from last year.
  • As of Q1 2025, Sunshine Biopharma's Short-term Investments stood at $70457.0.
  • Over the past 5 years, Sunshine Biopharma's Short-term Investments peaked at $70457.0 during Q1 2025, and registered a low of $7590.0 during Q1 2021.
  • Over the past 3 years, Sunshine Biopharma's median Short-term Investments value was $7590.0 (recorded in 2021), while the average stood at $15448.4.
  • Within the past 5 years, the most significant YoY rise in Sunshine Biopharma's Short-term Investments was 0.0% (2021), while the steepest drop was 0.0% (2021).
  • Over the past 3 years, Sunshine Biopharma's Short-term Investments (Quarter) stood at $7590.0 in 2021, then changed by 0.0% to $7590.0 in 2022, then soared by 828.29% to $70457.0 in 2025.
  • Its Short-term Investments was $70457.0 in Q1 2025, compared to $7590.0 in Q3 2022 and $7590.0 in Q2 2022.